IL108092A - Amino acid derivatives which inhibit hiv protease, process for their preparation and pharmaceutical compositions containing them - Google Patents

Amino acid derivatives which inhibit hiv protease, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL108092A
IL108092A IL108092A IL10809293A IL108092A IL 108092 A IL108092 A IL 108092A IL 108092 A IL108092 A IL 108092A IL 10809293 A IL10809293 A IL 10809293A IL 108092 A IL108092 A IL 108092A
Authority
IL
Israel
Prior art keywords
amino
butyl
aza
hydroxy
oxo
Prior art date
Application number
IL108092A
Other languages
English (en)
Other versions
IL108092A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/134,329 external-priority patent/US5733906A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL108092A0 publication Critical patent/IL108092A0/xx
Publication of IL108092A publication Critical patent/IL108092A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL108092A 1992-12-22 1993-12-20 Amino acid derivatives which inhibit hiv protease, process for their preparation and pharmaceutical compositions containing them IL108092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99525692A 1992-12-22 1992-12-22
US08/134,329 US5733906A (en) 1993-10-12 1993-10-12 Inhibitors of HIV Protease useful for the treatment of Aids

Publications (2)

Publication Number Publication Date
IL108092A0 IL108092A0 (en) 1994-04-12
IL108092A true IL108092A (en) 1998-06-15

Family

ID=26832220

Family Applications (1)

Application Number Title Priority Date Filing Date
IL108092A IL108092A (en) 1992-12-22 1993-12-20 Amino acid derivatives which inhibit hiv protease, process for their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US5905077A (fr)
EP (1) EP0604185B1 (fr)
JP (1) JPH06271534A (fr)
KR (1) KR940014337A (fr)
CN (1) CN1044117C (fr)
AT (1) ATE178055T1 (fr)
AU (1) AU667146B2 (fr)
BR (1) BR9305162A (fr)
CA (1) CA2112042A1 (fr)
CZ (1) CZ281493A3 (fr)
DE (1) DE69324120T2 (fr)
ES (1) ES2132201T3 (fr)
FI (1) FI935778A7 (fr)
HU (1) HUT69693A (fr)
IL (1) IL108092A (fr)
MX (1) MX9308016A (fr)
MY (1) MY131388A (fr)
NO (1) NO934719L (fr)
NZ (1) NZ250491A (fr)
PL (1) PL301581A1 (fr)
TW (1) TW262468B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1649H (en) 1987-07-31 1997-05-06 Barrish; Joel C. HIV protease inhibitor combinations
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
JPH07504654A (ja) 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
US5484926A (en) 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5461154A (en) * 1994-02-02 1995-10-24 Eli Lilly And Company Intermediate and process for making
TW472047B (en) * 1994-02-04 2002-01-11 Merck & Co Inc Process for making HIV protease inhibitors
EP0710652B1 (fr) * 1994-11-04 1998-03-04 Yamakawa Chemical Industry Co., Ltd. Procédé pour la préparation des dérivés de pipérazine optiquement actifs et produits intermédiaires pour leur préparation
CA2186483A1 (fr) * 1995-02-03 1996-08-08 Akira Nishiyama Procedes de production d'.alpha.-halocetones, d'.alpha.-halohydrines et d'epoxydes
US5618937A (en) * 1995-03-15 1997-04-08 Merck & Co., Inc. Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide
US5932550A (en) * 1995-06-30 1999-08-03 Japan Energy Corporation Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
US6222043B1 (en) 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
PT983999E (pt) * 1995-09-26 2005-05-31 Agouron Pharma Processo para a producao de derivados amida e dos seus intermediarios
DK0984000T3 (da) * 1995-09-26 2009-04-06 Japan Tobacco Inc Fremgangsmåde til fremstilling af amidderivater og intermediatforbindelser
EP0910564B1 (fr) * 1995-11-28 2007-10-31 Cephalon, Inc. Inhibiteurs de cysteine et serine proteases derives d'acides amine d
US5962725A (en) 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US6291432B1 (en) 1996-12-27 2001-09-18 Japan Energy Corporation Tripeptide compounds and anti-AIDS medicine
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
AU734766B2 (en) 1997-03-14 2001-06-21 Atlas Pharmaceuticals Inc. Agent for preventing and/or treating cachexia
US6538006B1 (en) * 1998-07-08 2003-03-25 Pharmacia Corporation Retroviral protease inhibitors
NZ525513A (en) 1998-08-07 2004-09-24 Pont Pharmaceuticals Du Succinoylamino lactams as inhibitors of Abeta protein production
HRP990246A2 (en) * 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
EP1313426A2 (fr) 1998-12-24 2003-05-28 Bristol-Myers Squibb Pharma Company Benzodiazepines succinoylamino utilisees comme inhibiteurs de la production de proteine a-beta
US6960576B2 (en) * 1999-09-13 2005-11-01 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
US6503902B2 (en) 1999-09-13 2003-01-07 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
WO2001027108A1 (fr) 1999-10-08 2001-04-19 Bristol-Myers Squibb Pharma Company AMINO SULFONAMIDES DE LACTAME UTILISES COMME INHIBITEURS DE LA PRODUCTION DE PROTEINE A$g(b)
US6525044B2 (en) 2000-02-17 2003-02-25 Bristol-Myers Squibb Company Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein production
US6495540B2 (en) 2000-03-28 2002-12-17 Bristol - Myers Squibb Pharma Company Lactams as inhibitors of A-β protein production
JP2004508289A (ja) 2000-04-03 2004-03-18 デュポン　ファーマシューティカルズ　カンパニー Ａβタンパク質産生の阻害剤としての環状ラクタム
CN1436175A (zh) 2000-04-03 2003-08-13 布里斯托尔-迈尔斯斯奎布药品公司 作为Aβ－蛋白生产抑制剂的环状内酰胺
US20100009966A1 (en) * 2001-04-11 2010-01-14 Bristol-Myers Squibb Pharma Company Substituted lactams as inhibitors of abeta protein production
CA2404273A1 (fr) * 2000-04-11 2001-10-18 Bristol-Myers Squibb Pharma Company Lactames substitues utilises en tant qu'inhibiteurs de production de proteine a.beta.
US6878363B2 (en) * 2000-05-17 2005-04-12 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
EP1268450A1 (fr) * 2000-06-01 2003-01-02 Bristol-Myers Squibb Pharma Company Lactames substitues par des succinates cycliques en tant qu'inhibiteurs de la production de la proteine beta
GB0028483D0 (en) 2000-11-22 2001-01-10 Hoffmann La Roche Hydroxyethylamine HIV protease inhibitors
WO2002064553A1 (fr) * 2001-02-14 2002-08-22 Kureha Chemical Industry Company, Limited Procede de preparation de derives d'alcools halogenes
US20090062256A1 (en) * 2001-06-01 2009-03-05 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
GB0123467D0 (en) 2001-09-28 2001-11-21 Hoffmann La Roche Carbocyclic HIV Protease inhibitors
KR101155335B1 (ko) * 2005-01-07 2012-06-11 엘지전자 주식회사 이동통신 단말기의 멀티미디어 메시지 동작방법
EP1910317B1 (fr) 2005-07-20 2013-07-03 Eli Lilly And Company Composés joints en position 1-amino
CN101508664B (zh) * 2009-02-25 2012-08-22 江阴希迪医药科技有限公司 N-苄氧羰基-3-氨基-1-氯-4-苯硫基-2-丁醇合成方法
KR20130124291A (ko) 2010-07-02 2013-11-13 길리애드 사이언시즈, 인코포레이티드 Ｈｉｖ 항바이러스 화합물로서의 2-퀴놀리닐-아세트산 유도체
AP2013006706A0 (en) * 2010-07-02 2013-02-28 Gilead Sciences Inc Napht-2-ylacetic acid derivatives to treat AIDS
BR112013027096A2 (pt) 2011-04-21 2016-12-27 Gilead Sciences Inc compostos de benzotiazol e seu uso farmacêutico
WO2013103724A1 (fr) 2012-01-04 2013-07-11 Gilead Sciences, Inc. Dérivés d'acide 2-(tert-butoxy)-2-(7-méthylquinoléin-6-yl)acétique pour traiter le sida
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
ES2571479T3 (es) 2012-04-20 2016-05-25 Gilead Sciences Inc Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5142056A (en) * 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA1340588C (fr) 1988-06-13 1999-06-08 Balraj Krishan Handa Derive d'aminoacides
EP0361341A3 (fr) * 1988-09-28 1991-07-03 Miles Inc. Agents thérapeutiques contre le SIDA basés sur des inhibiteurs des protéases du HIV
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
EP0813868B1 (fr) 1990-11-19 2005-06-01 Monsanto Company Inhibiteurs de protéases rétrovirales
ZA92913B (en) * 1991-02-08 1993-05-06 Sankyo Co New beta-amino-alpha hydroxycarboxylic acids and ttheir use
US5430041A (en) * 1991-05-10 1995-07-04 Hoffmann-La Roche Inc. Amino acid derivatives having antiviral activity
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂
WO1993013066A1 (fr) 1991-12-20 1993-07-08 Syntex (U.S.A.) Inc. Amides cycliques d'acides 3-amino-2-hydroxy-carboxyliques utilises comme inhibiteurs de la protease du vih
US5312820A (en) * 1992-07-17 1994-05-17 Merck & Co., Inc. Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines

Also Published As

Publication number Publication date
AU5252893A (en) 1994-07-07
DE69324120T2 (de) 1999-11-25
US5905077A (en) 1999-05-18
CN1044117C (zh) 1999-07-14
AU667146B2 (en) 1996-03-07
DE69324120D1 (de) 1999-04-29
EP0604185A1 (fr) 1994-06-29
PL301581A1 (en) 1994-06-27
ES2132201T3 (es) 1999-08-16
HUT69693A (en) 1995-09-28
KR940014337A (ko) 1994-07-18
TW262468B (fr) 1995-11-11
MX9308016A (es) 1994-08-31
CZ281493A3 (en) 1994-07-13
EP0604185B1 (fr) 1999-03-24
CA2112042A1 (fr) 1994-06-23
BR9305162A (pt) 1994-11-01
NO934719D0 (no) 1993-12-20
NZ250491A (en) 1995-08-28
MY131388A (en) 2007-08-30
FI935778A0 (fi) 1993-12-21
NO934719L (no) 1994-06-23
ATE178055T1 (de) 1999-04-15
CN1094399A (zh) 1994-11-02
IL108092A0 (en) 1994-04-12
JPH06271534A (ja) 1994-09-27
FI935778A7 (fi) 1994-06-23

Similar Documents

Publication Publication Date Title
EP0604185B1 (fr) Inhibiteurs de la HIV protéase pour le traitement du SIDA
US5502061A (en) Peptidyl substituted benzamides and naphthamies
EP0604183B1 (fr) Inhibiteurs de la HIV protéase utiles dans le traitement du Sida
CA2182192A1 (fr) Inhibiteurs de protease
EP0604184B1 (fr) Inhibiteurs de la HIV protéase utiles dans le traitement du Sida
CA2112052A1 (fr) Inhibiteurs de la protease du vih pour le traitement du sida
US5733906A (en) Inhibitors of HIV Protease useful for the treatment of Aids
US5578608A (en) Symmetrical diaryl and diheteroanyl cis epoxy alkanes antiviral compounds
US5461154A (en) Intermediate and process for making
US5491166A (en) Inhibitors of HIV protease useful for the treatment of AIDS
US5475136A (en) Inhibitors of HIV protease useful for the treatment of AIDS

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed